Sarcoma News

Chemotherapy treatment before surgical decompression improves survivability for a patient with Ewing sarcoma in the spine, as researchers determined in a retrospective study that chemotherapy is the superior impact factor to control the cancer.

The risk for a second solid cancer among survivors of Hodgkin’s lymphoma did not improve among patients treated in the 1990s compared with those treated in earlier periods, according to study results published in The New England Journal of Medicine.

Researchers at University of Michigan Comprehensive Cancer Center developed a new first-of-its-kind mobile app to help patients with breast cancer manage and navigate the multitude of information that accompanies a cancer diagnosis.

Issues surrounding nutrition and weight management are significantly more pressing now than they were decades ago when obesity was relatively uncommon.

Hyperactivation of the RAS/mitogen-activated protein kinases pathway appeared to play a role in the aggressiveness of undifferentiated pleomorphic sarcomas, according to study results.

Cancer affects not only the patient, but also family and friends who care for that person.

St. Jude-Washington University Pediatric Cancer Genome Project yields ‘important new findings’ in childhood malignancies

Beta-catenin and insulinlike growth factor 1 receptor appeared associated with poor disease-specific survival in patients with vascular leiomyosarcomas, according to retrospective study results published in JAMA Surgery.

When an adolescent or young adult receives a cancer diagnosis, their life is completely interrupted.

The antitumor drug trabectedin demonstrated superior disease control compared with conventional chemotherapy among patients with advanced liposarcoma and leiomyosarcoma who failed after prior chemotherapy, according to the results of a phase 3 randomized controlled trial.